University of Alabama at Birmingham (UAB), Birmingham, Alabama, USA.
TED University, Ankara, Turkey.
AIDS Patient Care STDS. 2021 Nov;35(11):441-448. doi: 10.1089/apc.2021.0096.
Stigma in health care settings can have negative consequences on women living with HIV, such as increasing the likelihood of missed visits and reducing trust in their clinical providers. Informed by prior stigma research and considering knowledge gaps related to the effect of patient-provider race concordance, we conducted this study to assess if patient-provider race concordance moderates the expected association between HIV-related stigma in health care settings and patients' trust in their providers. Moderation analyses were conducted using Women's Interagency HIV Study data ( = 931). We found significant main effects for patient-provider race concordance. Higher experienced stigma was associated with lower trust in providers in all patient-provider race combinations [White-White: = -0.89, standard error (SE) = 0.14, = 0.000, 95% confidence interval, CI (-1.161 to -0.624); Black patient-White provider: = -0.19, SE = 0.06, = 0.003, 95% CI (-0.309 to -0.062); and Black-Black: = -0.30, SE = 0.14, = 0.037, 95% CI (-0.575 to -0.017)]. Higher stigma was also associated with lower trust in providers [White-White: = -0.42, SE = 0.07, = 0.000, 95% CI (-0.552 to -0.289); Black patient-White provider: = -0.17, SE = 0.03, = 0.000, 95% CI (-0.232 to -0.106); and Black-Black: = -0.18, SE = 0.06, = 0.002, 95% CI (-0.293 to -0.066)]. Significant interaction effects indicated that the negative associations between experienced and anticipated HIV-related stigma and trust in providers were stronger for the White-White combination compared with the others. Thus, we found that significant relationships between HIV-related experienced and anticipated stigma in health care settings and trust in providers exist and that these associations vary across different patient-provider race combinations. Given that reduced trust in providers is associated with antiretroviral medication nonadherence and higher rates of missed clinical visits, interventions to address HIV-related stigma in health care settings may improve continuum of care outcomes.
在医疗环境中,污名化可能对感染艾滋病毒的妇女产生负面影响,例如增加错过就诊的可能性,并降低她们对临床提供者的信任。根据先前的污名研究,并考虑到与患者-提供者种族一致性相关的知识差距,我们进行了这项研究,以评估患者-提供者种族一致性是否调节了医疗保健环境中与艾滋病毒相关的污名与患者对提供者信任之间的预期关联。使用妇女间艾滋病毒研究数据(n=931)进行了调节分析。我们发现患者-提供者种族一致性存在显著的主要效应。在所有患者-提供者种族组合中,经历的污名程度越高,对提供者的信任度越低[白种人-白种人:β=-0.89,标准误差(SE)=0.14,p=0.000,95%置信区间(CI)(-1.161 至-0.624);黑人患者-白人提供者:β=-0.19,SE=0.06,p=0.003,95%CI(-0.309 至-0.062);黑种人-黑种人:β=-0.30,SE=0.14,p=0.037,95%CI(-0.575 至-0.017)]。较高的污名也与提供者的较低信任度相关[白种人-白种人:β=-0.42,SE=0.07,p=0.000,95%CI(-0.552 至-0.289);黑人患者-白人提供者:β=-0.17,SE=0.03,p=0.000,95%CI(-0.232 至-0.106);黑种人-黑种人:β=-0.18,SE=0.06,p=0.002,95%CI(-0.293 至-0.066)]。显著的交互作用效应表明,与其他组合相比,白种人-白种人组合中经历的和预期的与艾滋病毒相关的污名与提供者之间的信任之间的负面关联更强。因此,我们发现,在医疗保健环境中,与艾滋病毒相关的经历和预期的污名与提供者的信任之间存在显著的关系,并且这些关联因不同的患者-提供者种族组合而异。鉴于提供者的信任度降低与抗逆转录病毒药物不依从和错过临床就诊的比率较高有关,因此,解决医疗保健环境中与艾滋病毒相关的污名问题的干预措施可能会改善连续护理的结果。